These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 23836444)

  • 1. Cost of illness for neuromuscular diseases in the United States.
    Larkindale J; Yang W; Hogan PF; Simon CJ; Zhang Y; Jain A; Habeeb-Louks EM; Kennedy A; Cwik VA
    Muscle Nerve; 2014 Mar; 49(3):431-8. PubMed ID: 23836444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic costs of diabetes in the U.S. In 2007.
    American Diabetes Association
    Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic cost of fecal incontinence.
    Xu X; Menees SB; Zochowski MK; Fenner DE
    Dis Colon Rectum; 2012 May; 55(5):586-98. PubMed ID: 22513438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic burden of schizophrenia: empirical analyses from a survey in Thailand.
    Phanthunane P; Whiteford H; Vos T; Bertram M
    J Ment Health Policy Econ; 2012 Mar; 15(1):25-32. PubMed ID: 22611090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profile of medical care costs in patients with amyotrophic lateral sclerosis in the Medicare programme and under commercial insurance.
    Meng L; Bian A; Jordan S; Wolff A; Shefner JM; Andrews J
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 Feb; 19(1-2):134-142. PubMed ID: 28891333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Financial burden of hepatitis B-related diseases and factors influencing the costs in Shenzhen, China].
    Liang S; Zhang SX; Ma QS; Xiao HW; Lü QY; Xie X; Mei SJ; Hu DS; Zhou BP; Li B; Chen JF; Cui FQ; Wang FZ; Liang XF
    Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Dec; 31(12):1340-5. PubMed ID: 21223660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The economic burden of chronic obstructive pulmonary disease (COPD) in a U.S. Medicare population.
    Menzin J; Boulanger L; Marton J; Guadagno L; Dastani H; Dirani R; Phillips A; Shah H
    Respir Med; 2008 Sep; 102(9):1248-56. PubMed ID: 18620852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rising annual costs of dizziness presentations to U.S. emergency departments.
    Saber Tehrani AS; Coughlan D; Hsieh YH; Mantokoudis G; Korley FK; Kerber KA; Frick KD; Newman-Toker DE
    Acad Emerg Med; 2013 Jul; 20(7):689-96. PubMed ID: 23859582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of rosuvastatin use on costs and outcomes in patients at high risk for cardiovascular disease in US managed care and medicare populations: A data analysis.
    Huse DM; Song X; Ozminkowski RJ; Maguire J; Williams SA; Borok GM; McDonough K
    Clin Ther; 2006 Sep; 28(9):1425-42. PubMed ID: 17062315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating Societal Cost of Illness and Patients' Quality of Life of Duchenne Muscular Dystrophy in Egypt.
    Shehata ZH; Rabea H; El Sherif R; Abdelrahim ME; Dawoud DM
    Value Health Reg Issues; 2023 Jan; 33():10-16. PubMed ID: 36162195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outpatient rehabilitation for chronic neuromuscular diseases.
    Koch SJ; Arego DE; Bowser B
    Am J Phys Med; 1986 Oct; 65(5):245-57. PubMed ID: 3766710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of health care costs for chiropractic and medical patients.
    Stano M
    J Manipulative Physiol Ther; 1993 Jun; 16(5):291-9. PubMed ID: 8345311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Motor vehicle safety, health care, and taxes. National Highway Traffic Safety Administration, U.S. Department of Transportation.
    Prehosp Disaster Med; 1994; 9(1):11-23. PubMed ID: 10155483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. National health care costs of peripheral arterial disease in the Medicare population.
    Hirsch AT; Hartman L; Town RJ; Virnig BA
    Vasc Med; 2008 Aug; 13(3):209-15. PubMed ID: 18687757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence, utilization, and costs associated with acute respiratory conditions, United States, 1980.
    Harlan WR; Murt HA; Thomas JW; Lepkowski JM; Guire KE; Parsons PE; Berki SE; Landis JR
    Natl Med Care Util Expend Surv C; 1986 Sep; (4):1-63. PubMed ID: 10313514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic costs of overactive bladder in the United States.
    Ganz ML; Smalarz AM; Krupski TL; Anger JT; Hu JC; Wittrup-Jensen KU; Pashos CL
    Urology; 2010 Mar; 75(3):526-32, 532.e1-18. PubMed ID: 20035977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Socioeconomic costs of amyotrophic lateral sclerosis according to staging system.
    Oh J; An JW; Oh SI; Oh KW; Kim JA; Lee JS; Kim SH
    Amyotroph Lateral Scler Frontotemporal Degener; 2015 Jun; 16(3-4):202-8. PubMed ID: 25646865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Juvenile obesity and comorbidity type 2 diabetes mellitus (T2 DM) in Germany: development and cost-of-illness analysis].
    Wolfenstetter SB
    Gesundheitswesen; 2006 Oct; 68(10):600-12. PubMed ID: 17099820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimated cost of treating myasthenia gravis in an insured U.S. population.
    Guptill JT; Sharma BK; Marano A; Soucy A; Krueger A; Sanders DB
    Muscle Nerve; 2012 Mar; 45(3):363-6. PubMed ID: 22334170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The burden of illness associated with hepatocellular carcinoma in the United States.
    Lang K; Danchenko N; Gondek K; Shah S; Thompson D
    J Hepatol; 2009 Jan; 50(1):89-99. PubMed ID: 18977551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.